Cargando…
A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings
A quantitative polymerase chain reaction-enzyme immunoassay (Q-PCR-EIA) was developed to measure the amount of human papillomavirus (HPV) 16 DNA per genome equivalent in cervical scrapings. The quantitative approach was based on a combined competitive PCR for both HPV 16, using the general primer GP...
Autores principales: | Jacobs, M V, Walboomers, J M M, Beek, J van, Voorhorst, F J, Verheijen, R H M, Meijer, C J L M, Brule, A J C van den, Helmerhorst, ThJ M, Snijders, P J F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374354/ https://www.ncbi.nlm.nih.gov/pubmed/10487621 http://dx.doi.org/10.1038/sj.bjc.6690659 |
Ejemplares similares
-
Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction.
por: de Roda Husman, A. M., et al.
Publicado: (1995) -
High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum
por: Nobbenhuis, M A E, et al.
Publicado: (2002) -
Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
por: Cromme, F. V., et al.
Publicado: (1993) -
Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
por: Nobbenhuis, M A E, et al.
Publicado: (2001) -
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)